Department of Family and Community Medicine, University of Toronto, Toronto, Canada.
Department of Emergency Medicine, University of British Columbia, Vancouver, Canada.
J Travel Med. 2020 Dec 23;27(8). doi: 10.1093/jtm/taaa212.
With air travel restarting, there has been much discourse about the safety of flying during the pandemic. In travel medicine, risk assessment includes estimating baseline risk to the traveller, recognizing factors that may modify that risk, considering the role of interventions to decrease that risk and accounting for a traveller's perception and tolerance of risk. The goals of this review are to identify the in-flight transmission risks of commercial air travel, provide recommendations about the risks of flying during the pandemic and propose strategies to mitigate the spread of COVID-19.
The airline industry has taken a layered approach to increase passenger safety through effective onboard ventilation, extended ventilation at the gate, boarding and deplaning strategies, improved aircraft disinfection and pre-flight screening such as temperature checks and COVID-19 testing. Proximity to an index case may contribute to the risk of transmission more than the seat type or location. The use of face masks has significantly reduced onboard transmission, and mandatory in-flight mask-wearing policies are being enforced. Innovations such as digital health passports may help standardize screening entry requirements at airports and borders, allowing for a safer return to travel.
In-flight transmission of SARS-CoV-2 is a real risk, which may be minimized by combining mitigation strategies and infection prevention measures including mandatory masking onboard, minimizing unmasked time while eating, turning on gasper airflow in-flight, frequent hand sanitizing, disinfecting high touch surfaces, promoting distancing while boarding and deplaning, limiting onboard passenger movement, implementing effective pre-flight screening measures and enhancing contact tracing capability. Assessing risk is a cornerstone of travel medicine. It is important to evaluate the multiple factors contributing to the cumulative risk of an individual traveller during the COVID-19 pandemic and to employ a multi-pronged approach to reduce that risk.
随着航空旅行的重启,人们对大流行期间飞行的安全性展开了大量讨论。在旅行医学中,风险评估包括估计旅行者的基线风险、识别可能改变风险的因素、考虑降低风险的干预措施的作用以及考虑旅行者对风险的感知和承受能力。本综述的目的是确定商业航空旅行中的飞行中传播风险,提供有关大流行期间飞行风险的建议,并提出策略来减轻 COVID-19 的传播。
航空业采取了分层方法,通过有效提高客舱通风、延长登机口、登机和下机时的通风时间、改进飞机消毒和登机前筛查(如体温检查和 COVID-19 检测)来提高乘客安全性。与索引病例的接近程度可能比座位类型或位置更能增加传播的风险。戴口罩大大降低了机上传播的风险,强制佩戴口罩的政策正在实施。数字健康护照等创新技术可能有助于标准化机场和边境的筛查入境要求,使旅行更安全地恢复。
SARS-CoV-2 在飞行中的传播是一个真实的风险,可以通过结合减轻策略和感染预防措施来最小化,包括在机上强制佩戴口罩、在进食时尽量减少不戴口罩的时间、打开气流在飞行中、经常使用手部消毒剂、消毒高频接触表面、促进登机和下机时的距离、限制机上乘客的移动、实施有效的登机前筛查措施和增强接触者追踪能力。评估风险是旅行医学的基石。重要的是要评估导致 COVID-19 大流行期间个体旅行者累积风险的多个因素,并采取多管齐下的方法来降低风险。